Top News
Regeneron Pharmaceuticals acquires 23andMe’s Personal Genome Service, Total Health and Research Services businesses, and Biobank and related assets for $256 million at bankruptcy auction, beating out a bid from co-founder and former CEO…
Continue Reading
What You Should Know:
– Regeneron Pharmaceuticals, Inc. announced it has been named the successful bidder in the bankruptcy auction for substantially all of the assets of 23andMe Holding Co.
– Regeneron plans to acquire 23andMe’s…
Continue Reading
For the 164th episode of the Healthcare IT Today Podcast, we are talking about 23andMe and privacy! We kick this episode off by discussing 23andMe's declaration of bankruptcy to theorize what we think this…
Continue Reading
Several months have passed without a digital health IPO, but that’s about to change with virtual physical therapy business Hinge Health’s move to file an S-1 last month. MedCity News Editor-in-Chief Arundhati Parmar and…
Continue Reading
Top News
California-based consumer genetic testing company 23andMe files for Chapter 11 bankruptcy protection.
Co-founder Anne Wojcicki has stepped down as CEO, but remains on the board and plans to bid independently to buy the…
What You Should Know:
– 23andMe, a human genetics and biotechnology company, has announced its decision to initiate voluntary Chapter 11 proceedings in the U.S. Bankruptcy Court for the Eastern District of Missouri.
– The bankruptcy…
Continue Reading
Human genetics and biotechnology company 23andMe has filed for Chapter 11 proceedings in the U.S. Bankruptcy Court for the Eastern District of Missouri to facilitate a sales process. In a press release, the company said…
Continue Reading
Top News
Struggling consumer genetic testing company 23andMe considers selling its Lemonaid telehealth business.
23andMe acquired the business in 2021 for $400 million.
23andMe’s entire board resigned last September over differences in the company’s direction. It announced…
American Heart Association Ventures Invests in MDisrupt
Lisa Suennen, Managing Partner of American Heart Association Ventures and Longtime Healthcare Veteran, Joins the MDisrupt Board
MDisrupt’s Marketplace will be Made Available to Thousands of the American Heart…
What You Should Know:
– 23andMe Holding Co., a leading player in preventative health and therapeutics, and Nightingale Health, a pioneer in biomarker testing, announced a collaboration to pilot Nightingale’s blood metabolomics panel with a…
Continue Reading
